Thesis

New York, United States Founded: 2017 • Age: 9 yrs
Personalized nootropics for brain health are provided via quizzes.

About Thesis

Thesis is a Healthcare company based in New York (United States) founded in 2017 by Adam Greenfeld and Dan Freed. Personalized nootropics for brain health are provided via quizzes. It operates on a Direct-to-Consumer (D2C) and Subscription Services model. Thesis has raised $8.4 million across 1 funding round from investors including Unilever Ventures, REDO Ventures and ALIVE. Its website takethesis.com draws about 132 thousand monthly visits. Thesis offers products and services including Clarity, Motivation, Stress Reset, and Neuroprotection. Its focus areas include Supplements and Cognitive Health. Its competitors include Panaceutics, Wile and Gainful; 3 of its 3 listed competitors have raised funding.

Company details

Thesis is engaged in creating nootropic formulas aimed at enhancing cognitive functions such as focus, memory, and stress resilience. The company operates in the health and wellness sector, offering products designed to support brain health and performance. Solutions are developed through data-driven research and iterative testing to ensure effectiveness. Various formulations target specific needs like productivity, energy, balance, and long-term neuroprotection.

  • Headquarters New York, United States
  • Founders Adam Greenfeld, Dan Freed
  • Sectors
    Healthcare
  • Website category Health · Nutrition Diets and Fitness
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website takethesis.com
  • Social LinkedIn Facebook Instagram
Key Metrics
  • Annual Revenue
    $1.35 M (USD)
    as on Dec 31, 2022
  • Total Equity Funding
    $8.4M (USD)

    in 1 rounds

  • Latest Funding Round
    $8.4M (USD), Series A

    May 2023

  • Investors

Products & Services of Thesis

Thesis offers a comprehensive portfolio of products and services, including Clarity, Motivation, Stress Reset, and Neuroprotection.

Clarity
Nootropic Supplement

Concentration and focus are enhanced by this supplement.

Motivation
Nootropic Supplement

Brain energy and awareness are heightened by this product.

Stress Reset
Nootropic Supplement

Mental calm and resilience are supported by this formula.

Neuroprotection
Nootropic Supplement

Memory and brain health are supported by this supplement.

Funding Insights of Thesis

Thesis has successfully raised a total of $8.4M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.4 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8.4M
  • Total Rounds 1
  • Last Round Series A β€” $8.4M
  • First Round $8.4M

    (May 2023)

  • Investors Count 4

All 1 funding rounds of Thesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2023$8.4MSeries A––
Valuation history

4 investors in total: 4 institutional.

Investors in Thesis

Thesis has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Unilever Ventures, REDO Ventures and ALIVE.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Corporate-backed venture capital firm focused on consumer tech and multiple sectors
unileverventures.comLondon, United Kingdom
Investments are directed by REDO Ventures toward software technology startups.
redoventures.comNew York, United States
alivevc.com
An early-stage venture fund is operated by Break Trail Ventures.
breaktrailventures.comColumbus, USA
Premium access

Investor details for Thesis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Thesis

11 people are tracked at Thesis (6 in leadership, 5 in team).

NameRoleGroup
Adam Greenfeld
Co-FounderLeadership
Dan Freed
Co-FounderLeadership
Katy Marshall
Chief Business OfficerLeadership
Amrita Kisnasamy
Associate Director Of CXLeadership
Matthew Rubin
Vice President Supply ChainLeadership
Jessica Skoczylas
Director of Brand StrategyLeadership
Mohit Bahel
Strategic AdvisorTeam
Gary Kliegman
Consultant & AdvisorTeam
Patricia Bogdan
Senior Manager, Brand MarketingTeam
Will S.
Growth AnalystTeam
Peter MacRobert
AdvisorTeam
Premium access

Complete people profiles for Thesis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Thesis

2 dated milestones of Thesis across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Thesis is founded.
  2. Funding First funding round of $8.4M.

Competitors of Thesis

Thesis has 3 listed competitors in our database, 3 of them funded. They include Panaceutics, Wile and Gainful.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
panaceutics.com2013Danville, United States$11.88M
An online platform for personalized nutrition and medication is provided.
wilewomen.com2021Portland, United States$3M
Personalized supplements for women's wellness are offered via quizzes.
gainful.com2017San Francisco, United States$8.62M
Personalized protein powders and hydration products are manufactured for subscribers.
Premium access

Detailed competitors of Thesis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Thesis

The website of Thesis (takethesis.com) receives about 132.5K visits a month and ranks #273,204 among all websites worldwide, #801 in Nutrition Diets and Fitness.

  • Monthly visits
    132.5K

    ▲ 48.8% vs previous month

  • Unique visitors
    48.4K

    per month

  • Global rank
    #273,204

    among all websites

  • Category rank
    #801

    Health · Nutrition Diets and Fitness

Similar websites

Websites whose visitors overlap most with Thesis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
onnit.com
100%
409.8K#137,746View details
berkeleylife.com
berkeleylife.com
97%
#1,366,305–
doublewoodsupplements.com
96%
#220,346View details
naturalstacks.com
naturalstacks.com
96%
#695,148–
1stphorm.com
1stphorm.com
96%
#90,854–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 39 similar websites and full traffic analytics for Thesis

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 39 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Thesis (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M910
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Thesis

Premium access

Complete news archive for Thesis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thesis

Thesis was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Thesis is headquartered in New York, United States. It is registered at New York, New York, United States.

Thesis is a funded company, having raised a total of $8.4M across 1 funding round to date. The company's 1st funding round was a Series A of $8.4M, raised on May 2023.

Annual revenue of Thesis is $1.35M as on Dec 31, 2022.

Thesis is engaged in creating nootropic formulas aimed at enhancing cognitive functions such as focus, memory, and stress resilience. The company operates in the health and wellness sector, offering products designed to support brain health and performance. Solutions are developed through data-driven research and iterative testing to ensure effectiveness. Various formulations target specific needs like productivity, energy, balance, and long-term neuroprotection.

Thesis's top competitors include Gainful, Panaceutics and Wile.

Thesis offers Clarity, Motivation, Stress Reset, and Neuroprotection.

Thesis has 4 investors. Key investors include Unilever Ventures, REDO Ventures, ALIVE, and Break Trail Ventures.

The website of Thesis receives about 132 thousand visits a month and ranks #273,204 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available